Z Chen1, F Shi1, X Gong1, R Zhang1, W Zhong1, R Zhang1, Y Zhou1, M Lou2,3. 1. From the Department of Neurology (Z.C., F.S., X.G., R.Z., W.Z., R.Z., Y.Z., M.L.), Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China. 2. From the Department of Neurology (Z.C., F.S., X.G., R.Z., W.Z., R.Z., Y.Z., M.L.), Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China loumingxc@vip.sina.com. 3. Zhejiang University Brain Research Institute (M.L.), Hangzhou, Zhejiang, China.
Abstract
BACKGROUND AND PURPOSE: Thrombus permeability assessed on conventional CTA is associated with neurologic outcome in patients with acute ischemic stroke. We aimed to investigate whether dynamic CTA can improve the accuracy of thrombus permeability assessment and its predictive value for outcome. MATERIALS AND METHODS: We reviewed consecutive patients with acute ischemic stroke who had occlusion of the M1 segment of the middle artery cerebral artery and underwent pretreatment perfusion CT. Thrombus permeability, determined by thrombus attenuation increase (TAI), was assessed on 26-phase dynamic CTA derived from perfusion CT. TAImax was defined as the maximum TAI among phases; TAIpeak, as TAI of peak arterial phase; TAIcon, as TAI on phase 13. Good outcome was defined as a 3-month mRS score of ≤2. RESULTS: One hundred four patients were enrolled in the final analysis. The median TAImax, TAIpeak, and TAIcon were 30.1 HU (interquartile range, 13.0-50.2 HU), 9.5 HU (interquartile range, -1.6-28.7 HU), and 6.6 HU (interquartile range, -5.1-24.4 HU), respectively. Multivariable regression analyses showed that TAImax (OR = 1.027; 95% CI, 1.007-1.048; P = .008), TAIpeak (OR = 1.029; 95% CI, 1.005-1.054; P = .020), and TAIcon (OR = 1.026; 95% CI, 1.002-1.051; P = .037) were independently associated with good outcome. The areas under the ROC curve of TAImax, TAIpeak, and TAIcon in predicting good outcome were 0.734, 0.701, and 0.658, respectively. CONCLUSIONS: Thrombus permeability assessed on dynamic CTA could be a better predictor of outcome after reperfusion therapy than that assessed on conventional single-phase CTA.
BACKGROUND AND PURPOSE:Thrombus permeability assessed on conventional CTA is associated with neurologic outcome in patients with acute ischemic stroke. We aimed to investigate whether dynamic CTA can improve the accuracy of thrombus permeability assessment and its predictive value for outcome. MATERIALS AND METHODS: We reviewed consecutive patients with acute ischemic stroke who had occlusion of the M1 segment of the middle artery cerebral artery and underwent pretreatment perfusion CT. Thrombus permeability, determined by thrombus attenuation increase (TAI), was assessed on 26-phase dynamic CTA derived from perfusion CT. TAImax was defined as the maximum TAI among phases; TAIpeak, as TAI of peak arterial phase; TAIcon, as TAI on phase 13. Good outcome was defined as a 3-month mRS score of ≤2. RESULTS: One hundred four patients were enrolled in the final analysis. The median TAImax, TAIpeak, and TAIcon were 30.1 HU (interquartile range, 13.0-50.2 HU), 9.5 HU (interquartile range, -1.6-28.7 HU), and 6.6 HU (interquartile range, -5.1-24.4 HU), respectively. Multivariable regression analyses showed that TAImax (OR = 1.027; 95% CI, 1.007-1.048; P = .008), TAIpeak (OR = 1.029; 95% CI, 1.005-1.054; P = .020), and TAIcon (OR = 1.026; 95% CI, 1.002-1.051; P = .037) were independently associated with good outcome. The areas under the ROC curve of TAImax, TAIpeak, and TAIcon in predicting good outcome were 0.734, 0.701, and 0.658, respectively. CONCLUSIONS:Thrombus permeability assessed on dynamic CTA could be a better predictor of outcome after reperfusion therapy than that assessed on conventional single-phase CTA.
Authors: John Charles Benson; Sean T Fitzgerald; Ramanathan Kadirvel; Collin Johnson; Daying Dai; Doyle Karen; David F Kallmes; Waleed Brinjikji Journal: J Neurointerv Surg Date: 2019-06-25 Impact factor: 5.836
Authors: Raymond M Padmos; Nerea Arrarte Terreros; Tamás I Józsa; Gábor Závodszky; Henk A Marquering; Charles B L M Majoie; Stephen J Payne; Alfons G Hoekstra Journal: J R Soc Interface Date: 2022-10-05 Impact factor: 4.293
Authors: Nerea Arrarte Terreros; Bettine G van Willigen; Wera S Niekolaas; Manon L Tolhuisen; Josje Brouwer; Jonathan M Coutinho; Ludo Fm Beenen; Charles Blm Majoie; Ed van Bavel; Henk A Marquering Journal: J Cereb Blood Flow Metab Date: 2021-09-22 Impact factor: 6.960
Authors: Henrik Gensicke; James W Evans; Fahad S Al Ajlan; Dar Dowlatshahi; Mohamed Najm; Ana L Calleja; Josep Puig; Sung-lI Sohn; Seong H Ahn; Alexandre Y Poppe; Robert Mikulik; Negar Asdaghi; Thalia S Field; Albert Jin; Talip Asil; Jean-Martin Boulanger; Michael D Hill; Mayank Goyal; Andrew M Demchuk; Bijoy K Menon Journal: Neuroradiology Date: 2019-11-12 Impact factor: 2.804
Authors: Maria Berndt; Fabian Mück; Christian Maegerlein; Silke Wunderlich; Claus Zimmer; Stefan Wirth; Sebastian Mönch; Johannes Kaesmacher; Benjamin Friedrich; Tobias Boeckh-Behrens Journal: Clin Neuroradiol Date: 2020-09-29 Impact factor: 3.649